LRP5 and osteoporosis: In addition, the aberrant regulation of Wnt inhibitors such as Sclerostin (SOST) and Dickkopf (DKK), which bind to LRP5/6, was found to cause different bone diseases, such as sclerosteosis and osteoporosis [42].